Efficacy of the controlled release of concentrated platelet lysate from a collagen/gelatin scaffold for dermis-like tissue regeneration

Tissue Engineering - Part A

Volumn 19, Issue 11-12, 2013, Pages 1398-1405

  Ito, Ran ^a   Morimoto, Naoki ^b   Pham, Liem Hieu ^a   Taira, Tsuguyoshi ^c   Kawai, Katsuya ^a   Suzuki, Shigehiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c Gunze Research and Development Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL PROLIFERATION; CONCENTRATION (PROCESS); ENZYME INHIBITION; PLATELETS; REPAIR; TISSUE; TISSUE REGENERATION;

BASIC FIBROBLAST GROWTH FACTOR; CONTROLLED RELEASE; OPTIMAL CONCENTRATION; PLATELET-DERIVED GROWTH FACTORS; RELEASE EXPERIMENTS; SUSTAINED RELEASE; TRANSFORMING GROWTH FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

SCAFFOLDS (BIOLOGY);

MUS;

CELL EXTRACT; COLLAGEN; GELATIN; SIGNAL PEPTIDE; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL; ARTICLE; C57BL MOUSE; CAPILLARY; CHEMISTRY; DELAYED RELEASE FORMULATION; DERMIS; DRUG EFFECT; EPITHELIUM; HUMAN; MOUSE; PHYSIOLOGY; REGENERATION; SWINE; THROMBOCYTE; TIME; WOUND HEALING;

ANIMALS; BLOOD PLATELETS; CAPILLARIES; CELL EXTRACTS; COLLAGEN; DELAYED-ACTION PREPARATIONS; DERMIS; EPITHELIUM; GELATIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; SUS SCROFA; TIME FACTORS; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84876925281     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0375     Document Type: Article

References (55)

1. Yannas, IV., and Burke, J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14, 65, 1980.
2. Suzuki, S., Matsuda, K., Isshiki, N., Tamada, Y., and Ikada, Y. Experimental study of a newly developed bilayer artificial skin. Biomaterials 11, 356, 1990.
3. Suzuki, S., Matsuda, K., Maruguchi, T., Nishimura, Y., and Ikada, Y. Further applications of "bilayer artificial skin". Br J Plast Surg 48, 222, 1995.
4. Takemoto, S., Morimoto, N., Kimura, Y., Taira, T., Kitagawa, T., Tomihata, K., et al. Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF. Tissue Eng Part A 14, 1629, 2008.
5. Kanda, N., Morimoto, N., Takemoto, S., Ayvazyan, A.A., Kawai, K., Sakamoto, Y., et al. Efficacy of novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor for dermis-like tissue regeneration. Ann Plast Surg 69, 569, 2012.
6. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
7. Hokugo, A., Sawada, Y., Hokugo, R., Iwamura, H., Kobuchi, M., Kambara, T., et al. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104, 44, 2007.
8. Martinowitz, U., and Spotnitz, W.D. Fibrin tissue adhesives. Thromb Haemost 78, 661, 1997.
9. Folkman, J., Browder, T., and Palmblad, J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 86, 23, 2001.
10. Chen, F.M., Zhang, M., and Wu, Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31, 6279, 2010.
11. Marx, R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62, 489, 2004.
12. Margolis, D.J., Kantor, J., Santanna, J., Strom, B.L., and Berlin, J.A. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24, 483, 2001.
13. Bhanot, S., and Alex, J.C. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18, 27, 2002.
14. Man, D., Plosker, H., and Winland-Brown, J.E. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 107, 229, 2001.
15. Hee, H.T., Majd, M.E., Holt, R.T., and Myers, L. Do autologous growth factors enhance transforaminal lumbar interbody fusion? Eur Spine J, 12, 400, 2003.
16. Bir, S.C., Esaki, J., Marui, A., Yamahara, K., Tsubota, H., Ikeda, T., et al. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. J Vasc Surg 50, 870, 2009.
17. Pietramaggiori, G., Scherer, S.S., Mathews, J.C., Alperovich, M., Yang, H.J., Neuwalder, J., et al. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16, 218, 2008.
18. Sugimori, E., Shintani, S., Ishikawa, K., and Hamakawa, H. Effects of apatite foam combined with platelet-rich plasma on regeneration of bone defects. Dent Mater J 25, 591, 2006.
19. Steed, D.L., Goslen, J.B., Holloway, G.A., Malone, J.M., Bunt, T.J., and Webster, M.W. Randomized prospective doubleblind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15, 1598, 1992.
20. Robson, M.C., Phillips, L.G., Thomason, A., Altrock, B.W., Pence, P.C., Heggers, J.P., et al. Recombinant human plateletderived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg 29, 193, 1992.
21. Weibrich, G., Kleis, W.K., Kunz-Kostomanolakis, M., Loos, A.H., and Wagner, W. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Int J Oral Maxillofac Implants 16, 693, 2001.
22. Henderson, J.L., Cupp, C.L., Ross, E.V., Shick, P.C., Keefe, M.A., Wester, D.C., et al. The effects of autologous platelet gel on wound healing. Ear Nose Throat J 82, 598, 2003.
23. El-Sharkawy, H., Kantarci, A., Deady, J., Hasturk, H., Liu, H., Alshahat, M., et al. Platelet-rich plasma: growth factors and pro-and anti-inflammatory properties. J Periodontol 78, 661, 2007.
24. Nikolidakis, D., and Jansen, J.A. The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev 14, 249, 2008.
25. Knighton, D.R., Doucette, M., Fiegel, V.D., Ciresi, K., Butler, E., and Austin, L. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res 266, 319, 1988.
26. Pietramaggiori, G., Kaipainen, A., Czeczuga, J.M., Wagner, C.T., and Orgill, D.P. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen 14, 573, 2006.
27. Gonshor, A. Technique for producing platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restorative Dent 22, 547, 2002.
28. Harrison, P., and Cramer, E.M. Platelet alpha-granules. Blood Rev 7, 52, 1993.
29. Peattie, R.A., Pike, D.B., Yu, B., Cai, S., Shu, X.Z., Prestwich, G.D., et al. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv 15, 389, 2008.
30. Tabata, Y., Hong, L., Miyamoto, S., Miyao, M., Hashimoto, N., and Ikada, Y. Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1. J Biomater Sci Polym Ed 11, 891, 2000.
31. Schultz, G.S., and Grant, M.B. Neovascular growth factors. Eye (Lond) 5, 170, 1991.
32. Nicosia, R.F., Nicosia, S.V., and Smith, M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145, 1023, 1994.
33. Hellberg, C., Ostman, A., and Heldin, C.H. PDGF and vessel maturation. Recent Results Cancer Res 180, 103, 2010.
34. Bertrand-Duchesne, M.P., Grenier, D., and Gagnon, G. Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro. J Periodontal Res 45, 87, 2010.
35. Hoshi, R., Murata, S., Matsuo, R., Myronovych, A., Hashimoto, I., Ikeda, H., et al. Freeze-dried platelets promote hepatocyte proliferation in mice. Cryobiology 55, 255, 2007.
36. Taipale, J., and Keski-Oja, J. Growth factors in the extracellular matrix. FASEB J 11, 51, 1997.
37. Ayvazyan, A., Morimoto, N., Kanda, N., Takemoto, S., Kawai, K., Sakamoto, Y., et al. Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surg Res 171, e247, 2011.
38. Smith, S.E., and Roukis, T.S. Bone and wound healing augmentation with platelet-rich plasma. Clin Podiatr Med Surg 26, 559, 2009.
39. Hsu, C.W., Yuan, K., and Tseng, C.C. The negative effect of platelet-rich plasma on the growth of human cells is associated with secreted thrombospondin-1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107, 185, 2009.
40. El Backly, R., Ulivi, V., Tonachini, L., Cancedda, R., Descalzi, F., and Mastrogiacoma, M. Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response. Tissue Eng Part A 17, 1787, 2011.
41. Henry, G., Li, W., Garner, W., and Woodley, D.T. Migration of human keratinocytes in plasma and serum and wound reepithelialisation. Lancet 361, 574, 2003.
42. Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy, G., et al. Cell migration: integrating signals from front to back. Science 302, 1704, 2003.
43. Tanaka, E., Ase, K., Okuda, T., Okumura, M., and Nogimori, K. Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol Pharm Bull 19, 1141, 1996.
44. Okumura, M., Okuda, T., Nakamura, T., and Yajima, M. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 19, 530, 1996.
45. Motomura, K., Hagiwara, A., Komi-Kuramochi, A., Hanyu, Y., Honda, E., Suzuki, M., et al. An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection. Biochim Biophys Acta 1780, 1432, 2008.
46. Carmeliet, P. Angiogenesis in health and disease. Nat Med 9, 653, 2003.
47. Ferrara, N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280, C1358, 2001.
48. Müller, G., Behrens, J., Nussbaumer, U., Böhlen, P., and Birchmeier, W. Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci USA 84, 5600, 1987.
49. Facchiano, A., De Marchis, F., Turchetti, E., Facchiano, F., Guglielmi, M., Denaro, A., et al. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor. J Cell Sci 113, 2855, 2000.
50. De Marchis, F., Ribatti, D., Giampietri, C., Lentini, A., Faraone, D., Scoccianti, M., et al. Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. Blood 99, 2045, 2002.
51. Tengood, J.E., Ridenour, R., Brodsky, R., Russell, A.J., and Little, S.R. Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng Part A 17, 1181, 2011.
52. Ratanavaraporn, J., Furuya, H., Kohara, H., and Tabata, Y. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 32, 2797, 2011.
53. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
54. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
55. Hao, X., Silva, E.A., Mansson-Broberg, A., Grinnemo, K.H., Siddiqui, A.J., Dellgren, G., et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 75, 178, 2007.